Decline In New Starts Of Psychotropic Medications During The COVID-19 Pandemic.

Antipsychotic Agents / therapeutic use COVID-19 Humans Mental Disorders / drug therapy Pandemics Psychotropic Drugs / therapeutic use SARS-CoV-2

Journal

Health affairs (Project Hope)
ISSN: 1544-5208
Titre abrégé: Health Aff (Millwood)
Pays: United States
ID NLM: 8303128

Informations de publication

Date de publication:
06 2021
Historique:
entrez: 7 6 2021
pubmed: 8 6 2021
medline: 12 6 2021
Statut: ppublish

Résumé

COVID-19 interrupted delivery of mental health care in the US. During the initial course of the COVID-19 pandemic new starts of antidepressants declined by 7.5 percent, anxiolytics by 5.6 percent, and antipsychotics by 2.6 percent compared with expected levels. Our findings suggest that there is large unmet need for mental health treatment in the US due to COVID-19.

Identifiants

DOI: 10.1377/hlthaff.2021.00028 PMID: 34097524
pubmed: 34097524
doi: 10.1377/hlthaff.2021.00028
doi:

Substances chimiques

Antipsychotic Agents 0
Psychotropic Drugs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

904-909

Auteurs

Ian Nason (I)

Ian Nason (nason@g.harvard.edu) is a PhD candidate in the Department of Health Care Policy, Harvard Medical School, in Boston, Massachusetts.

Dorit T Stein (DT)

Dorit T. Stein is an incoming PhD student in the Department of Global Health and Population, Harvard T. H. Chan School of Public Health,in Boston, Massachusetts.

Richard G Frank (RG)

Richard G. Frank is the Margaret T. Morris Professor of Health Economics in the Department of Health Care Policy, Harvard Medical School.

Murray B Stein (MB)

Murray B. Stein is Distinguished Professor of Psychiatry and Public Health, University of California San Diego, in La Jolla, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents du système nerveux central › Psychoanaleptiques › Tranquillisants › Neuroleptiques › Decline In New Starts Of Psychotropic...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Decline In New Starts Of Psychotropic...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Decline In New Starts Of Psychotropic...
questionsmedicales.fr › Troubles mentaux › Decline In New Starts Of Psychotropic...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Épidémies de maladies › Épidémies › Pandémies › Decline In New Starts Of Psychotropic...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents du système nerveux central › Psychoanaleptiques › Decline In New Starts Of Psychotropic...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › Decline In New Starts Of Psychotropic...